Biosource International Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biosource International

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joe Dancy who wrote (164)	8/28/1997 4:49:00 PM
From: Robert T. Quasius	of 696

I was attracted to BioSource for the same reasons as you were. Very high growth rate, low P/E, clean balance sheet, and in the biotech field. I can't explain the low evaluations except for neglect. There is no reason at all for the low valuation. BTY, another similar company is NABI. Same story, medical products, high growth rate, clean balance sheet, low P/E. Opportunities like these abound with small/micro-cap stocks. I use Zacks to screen a large database and identify companys with high consensus long term growth rates, and low current and next fiscal year P/Es. I have done quite well buying undervalued high growth rate stocks. Seems like we have a similar investing philosophy. I think that as attention refocus from big cap to small cap, stocks like these will soar. Happy investing!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next